Jiamei Yang
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 28
- Liver physiology and pathology 5
- Liver Disease and Transplantation 4
- Cancer Research top 5%
- MicroRNA in disease regulation 4
-
- Cancer Mechanisms and Therapy 7
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 8
- Hepatitis B Virus Studies 4
- Oncology top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 16
- Co-authors
- Yanming ZhouWon Young TakJordi BruixJosep M. LlovetGerold MeinhardtGar-Yang ChauChengjun SuiBin Li
- Journals
- BMC Cancer (4 papers)World Journal of Surgical Oncology (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Jiamei Yang
48 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 1.7k
- Cancer Research 616
- Pathology and Forensic Medicine 506
- Epidemiology 801
- Oncology 538
Countries citing papers authored by Jiamei Yang
This map shows the geographic impact of Jiamei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiamei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiamei Yang more than expected).
Fields of papers citing papers by Jiamei Yang
This network shows the impact of papers produced by Jiamei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiamei Yang. The network helps show where Jiamei Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiamei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2021 | 17 | |
| 3 | 2019 | 18 | |
| 4 | 2016 | 85 | |
| 5 | Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialbreakdown → | 2016 | 479 |
| 6 | Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trialbreakdown → | 2015 | 771 |
| 7 | 2013 | 25 | |
| 8 | Is postoperative adjuvant transchatheter arterial chemoembolization necessary for small hepatocellular carcinoma patients: a randomized controlled trial | 2012 | 4 |
| 9 | 2012 | 86 | |
| 10 | 2011 | 19 | |
| 11 | 2011 | 24 | |
| 12 | 2011 | 10 | |
| 13 | Combination of thymosin-α_1 with low-dose gemcitabine for advanced non-small cell lung cancer in elderly patients | 2010 | 3 |
| 14 | Clinical study of comparative efficacy of DCF regimen vs. ECF regimen in treating advanced gastric cancer | 2010 | 1 |
| 15 | 2010 | 92 | |
| 16 | Recent Advances and Controversies in Surgical Management of Hepatocellular Carcinoma | 2008 | 0 |
| 17 | [The effect of postoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma]. | 2002 | 1 |
| 18 | 2002 | 1 | |
| 19 | Resection of caudate lobe carcinoma of the liver | 2000 | 0 |
| 20 | 2000 | 96 |
About Jiamei Yang
Jiamei Yang is a scholar working on Hepatology, Cancer Research and Pathology and Forensic Medicine, having authored 51 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Liver Disease Diagnosis and Treatment (8 papers), Cancer Mechanisms and Therapy (7 papers), Liver physiology and pathology (5 papers), MicroRNA in disease regulation (4 papers), Liver Disease and Transplantation (4 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Hepatology (1.7k citations), Cancer Research (616 citations) and Pathology and Forensic Medicine (506 citations). Jiamei Yang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yanming Zhou, Won Young Tak, Jordi Bruix, Josep M. Llovet, Gerold Meinhardt, Gar-Yang Chau, Chengjun Sui, Bin Li, Zhengfeng Yin and Kwan Sik Lee. Their work appears in journals such as BMC Cancer, World Journal of Surgical Oncology, Journal of Clinical Oncology, BMC Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.